Avicanna Inc. Insider Trading

TSX AVCN


5

All Trades

2

Significant

3

Notable

4

Clusters

5

Repeat

CompanyInsiderTitleDateSharesPriceValueBalanceIncreaseSignal
AvicannaKilic, OzgurDirector27-May-26160,000$0.14$21,856480,00050%NT CL RP
AvicannaMichael KottDirector25-May-26400,000$0.13$51,0002,811,27817%SI CL RP
AvicannaMichael KottDirector21-May-26369,500$0.14$50,0302,249,27820%SI RP
AvicannaKilic, OzgurDirector22-Apr-26202,500$0.16$31,833202,500NewNT CL RP
AvicannaMichael KottDirector20-Apr-26217,000$0.14$31,4651,757,27814%NT CL RP

Stock Chart

Company Info

Avicanna Inc. is a Canadian biotechnology company specializing in the research, development, and commercialization of plant-derived cannabinoid-based products. Established in 2016, the company is headquartered in Toronto, Ontario, Canada, where it serves as a hub for its advanced scientific innovation and global operations. Avicanna leverages its expertise to focus on evidence-based solutions in the pharmaceutical, medical, and wellness markets, offering a range of products that cater to diverse needs. The company is recognized for its emphasis on quality, compliance, and sustainability, aligning its operations with rigorous standards to ensure efficacy and safety in its offerings. Through its Toronto headquarters, Avicanna supports its extensive collaborations with leading academic and clinical institutions, fostering advancements in cannabinoid science. Its dedication to innovation and wellness has positioned it as a prominent leader in the cannabinoid-based product industry.






Don’t miss today’s trades

Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.

Subscribe Now